DJIA 17,003.67 -27.47 -0.16%
NASDAQ 4,505.21 -13.69 -0.30%
S&P 500 1,982.65 -1.48 -0.07%
market minute promo

50.15 0.20 (0.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $50.17 0.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.98
Previous Close $49.95
Daily Range $49.70 - $50.01
52-Week Range $44.37 - $57.49
Market Cap $83.1B
P/E Ratio 31.02
Dividend (Yield) $1.44 (2.9%)
Ex-Dividend Date
Dividend Pay Date
07/01/14
08/01/14
Volume 161,496
Average Daily Volume 4,675,774
Current FY EPS $1.77

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

The Surprising 7 States Where Melanoma Most Often Occurs

Of the seven most common types of cancer, melanoma incidence was the only one to rise between 2000 and 2009. Find out in which seven states melanoma occurs most often, as well as what's being done to curb this terrible form of skin cancer.

If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits

Teva Pharmaceutical Is Poised To Grow

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

In A Quiet Week, Affimed Therapeutics IPO Could Garner Investor Interest

Health Care Select Sector SPDR Fund Experiences Big Inflow

Insider Trading Alert - BMY, AMBA And MTD Traded By Insiders

3 Stocks Reiterated As A Buy: BMY, DIS, BIDU

Bristol-Myers Needs a Healthy Growth Shot to Justify Its Valuation

Bristol-Myers Sues Merck of Patent Infringement on Keytruda - Analyst Blog

Achillion - An Options Strategy For A Potential Acquisition

See More BMY News...

BMY's Top Competitors

BMY $50.15 (0.39%)
Current stock: BMY
JNJ $104.75 (0.03%)
Current stock: JNJ
NVS $93.85 (-0.35%)
Current stock: NVS
RHHBY $37.02 (0.16%)
Current stock: RHHBY